Löfgren’s Syndrome Following BNT162b2 mRNA COVID-19 Vaccination and Subsequent Plaque-type Cutaneous Sarcoidosis after its Resolution

Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, et al. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells 2021; 10: 766.

https://doi.org/10.3390/cells10040766 DOI: https://doi.org/10.3390/cells10040766

Löfgren S. Primary pulmonary sarcoidosis. I. Early sign and symptoms. Acta Med Scand 1953; 142: 424–431.

https://doi.org/10.1111/j.0954-6820.1953.tb07039.x DOI: https://doi.org/10.1111/j.0954-6820.1953.tb07039.x

Mañá J, Gomez-Vaquero C, Montero A, Salazar A, Marcoval J, Valverde J, et al. Löfgren’s syndrome revisited: a study of 186 patients. Am J Med 1999; 107: 240–245.

https://doi.org/10.1016/S0002-9343(99)00223-5 DOI: https://doi.org/10.1016/S0002-9343(99)00223-5

Flores R, Caridade S. Löfgren’s syndrome: clinical presentation, clinical course, and literature review. Cureus 2023; 15: e33651.

https://doi.org/10.7759/cureus.33651 DOI: https://doi.org/10.7759/cureus.33651

Marchell R, Judson MA. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 2007; 25: 295–302.

https://doi.org/10.1016/j.clindermatol.2007.03.007 DOI: https://doi.org/10.1016/j.clindermatol.2007.03.007

Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist. Part I. Cutaneous disease. J Am Acad Dermatol 2012; 66: 699.e1–699.e18.

https://doi.org/10.1016/j.jaad.2011.11.965 DOI: https://doi.org/10.1016/j.jaad.2011.11.965

Koneti J, Cherukuri SP, Gadde S, Kalluru R, Chikatimalla R, Dasaradhan T. Sarcoidosis and its dermatological manifestations: a narrative review. Cureus 2022; 14: e28053.

https://doi.org/10.7759/cureus.28053 DOI: https://doi.org/10.7759/cureus.28053

Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol 2021; 12: 714170.

https://doi.org/10.3389/fimmu.2021.714170 DOI: https://doi.org/10.3389/fimmu.2021.714170

Radmacher JG, Tampe B, Korsten P. First report of two cases of Löfgren’s syndrome after SARS-CoV-2 vaccination: coincidence or causality? Vaccines 2021; 9: 1313.

https://doi.org/10.3390/vaccines9111313 DOI: https://doi.org/10.3390/vaccines9111313

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383: 2603–2615.

https://doi.org/10.1056/NEJMoa2034577 DOI: https://doi.org/10.1056/NEJMoa2034577

McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 2021; 85: 46–55.

https://doi.org/10.1016/j.jaad.2021.03.092 DOI: https://doi.org/10.1016/j.jaad.2021.03.092

Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, et al. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol 2022; 61: 1187–1204.

https://doi.org/10.1111/ijd.16063 DOI: https://doi.org/10.1111/ijd.16063

Seol JE, Jang SH, Yun HW, Ahn SW, Kim H. A case of cutaneous sarcoidosis with pulmonary involvement after SARS-CoV-2 mRNA vaccination. JAAD Case Rep 2024; 50: 47–50.

https://doi.org/10.1016/j.jdcr.2024.05.019 DOI: https://doi.org/10.1016/j.jdcr.2024.05.019

Caplan HI, Katz WA, Rubenstein M. Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum 1970; 13: 101–111.

https://doi.org/10.1002/art.1780130201 DOI: https://doi.org/10.1002/art.1780130201

Torralba KD, Quismorio FP Jr. Sarcoid arthritis: a review of clinical features, pathology, and therapy. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 95–103.